ALKBH5 and neoplasm: In this connection, ALKBH5 knockdown act synergistically with both chemotherapeutic drugs to suppress tumor growth and induce apoptosis in CSCs, validating ALKBH5 as a druggable target to reverse chemoresistance in CRC.